Axim Biotechnologies Stock Current Valuation
| AXIM Stock | USD 0.01 0 16.15% |
Valuation analysis of Axim Biotechnologies helps investors to measure Axim Biotechnologies' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Axim Biotechnologies' price fluctuation is out of control at this time. Calculation of the real value of Axim Biotechnologies is based on 3 months time horizon. Increasing Axim Biotechnologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Axim Biotechnologies is useful when determining the fair value of the Axim otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Axim Biotechnologies. Since Axim Biotechnologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Axim OTC Stock. However, Axim Biotechnologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0109 | Real 0.0107 | Hype 0.01 |
The real value of Axim OTC Stock, also known as its intrinsic value, is the underlying worth of Axim Biotechnologies OTC Stock, which is reflected in its stock price. It is based on Axim Biotechnologies' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Axim Biotechnologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Axim Biotechnologies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Axim Biotechnologies helps investors to forecast how Axim otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Axim Biotechnologies more accurately as focusing exclusively on Axim Biotechnologies' fundamentals will not take into account other important factors: Axim Biotechnologies OTC Stock Current Valuation Analysis
Axim Biotechnologies' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Axim Biotechnologies Current Valuation | 13.6 M |
Most of Axim Biotechnologies' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axim Biotechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Axim Biotechnologies has a Current Valuation of 13.6 M. This is 99.91% lower than that of the Biotechnology sector and 99.71% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.92% higher than that of the company.
Axim Biotechnologies is the top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 4.76 Billion. Axim Biotechnologies adds roughly 13.6 Million in current valuation claiming only tiny portion of equities under Health Care industry.Axim Fundamentals
| Return On Equity | -100.19 | |||
| Return On Asset | -0.35 | |||
| Operating Margin | (847.86) % | |||
| Current Valuation | 13.6 M | |||
| Shares Outstanding | 186.44 M | |||
| Shares Owned By Insiders | 40.97 % | |||
| Price To Earning | (53.71) X | |||
| Price To Book | 2.86 X | |||
| Price To Sales | 943.93 X | |||
| Revenue | 60.46 K | |||
| Gross Profit | 60.46 K | |||
| EBITDA | (13.42 M) | |||
| Net Income | (16.03 M) | |||
| Cash And Equivalents | 65.16 K | |||
| Total Debt | 5.06 M | |||
| Debt To Equity | 1.36 % | |||
| Current Ratio | 0.06 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (2.49 M) | |||
| Earnings Per Share | (0.13) X | |||
| Beta | 1.49 | |||
| Market Capitalization | 4.64 M | |||
| Total Asset | 5.32 M | |||
| Retained Earnings | (36.37 M) | |||
| Working Capital | (1.36 M) | |||
| Current Asset | 1.18 M | |||
| Current Liabilities | 2.55 M | |||
| Z Score | -15.0 | |||
| Net Asset | 5.32 M |
About Axim Biotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axim Biotechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axim Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axim Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Axim Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Axim Biotechnologies' short interest history, or implied volatility extrapolated from Axim Biotechnologies options trading.
Pair Trading with Axim Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axim Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axim Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving against Axim OTC Stock
| 0.9 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
| 0.86 | CE | Celanese Financial Report 14th of May 2024 | PairCorr |
| 0.85 | CAT | Caterpillar Earnings Call This Week | PairCorr |
| 0.84 | DIS | Walt Disney Report 8th of May 2024 | PairCorr |
| 0.81 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
The ability to find closely correlated positions to Axim Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axim Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axim Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axim Biotechnologies to buy it.
The correlation of Axim Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axim Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axim Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axim Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axim Biotechnologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Axim OTC Stock analysis
When running Axim Biotechnologies' price analysis, check to measure Axim Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axim Biotechnologies is operating at the current time. Most of Axim Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Axim Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axim Biotechnologies' price. Additionally, you may evaluate how the addition of Axim Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |